Trial Profile
A phase II study to evaluate KM-023 for HIV infections.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2017
Price :
$35
*
At a glance
- Drugs Ainuovirine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 25 Jan 2017 New trial record